Lapatinib Ditosylate(CAS: 388082-77-7)

Lapatinib Ditosylate (CAS: 388082-77-7) is a pharmaceutical compound used as a tyrosine kinase inhibitor. Its chemical formula is C21H26N2O11S2, and it is a white, crystalline powder with high water solubility. It is commonly used in drug formulations for cancer treatment, particularly targeting HER2-positive breast cancer. The tosylate salt form enhances its stability and bioavailability in medicinal applications.

Lapatinib Ditosylate (CAS: 388082-77-7) is primarily used in pharmaceuticals as a targeted therapy for HER2-positive breast cancer. It inhibits the growth of cancer cells by blocking specific protein receptors. Additionally, it is employed in research for studying kinase pathways and in drug development for creating cancer treatment options. Its applications are limited to medicinal and scientific fields due to its specialized chemical properties.

Lapatinib Ditosylate (CAS: 388082-77-7) is generally safe when used as directed in medical settings. However, it may cause side effects such as diarrhea, nausea, and fatigue. Handling precautions include wearing gloves and eye protection to avoid skin contact or inhalation. Safety standards require proper storage and administration by trained professionals to ensure efficacy and minimize risks.

Lapatinib Ditosylate (CAS: 388082-77-7) should be stored in a cool, dry place at 2-8°C, protected from light. Keep it in a sealed, airtight container made of glass or plastic to prevent moisture absorption. Avoid exposure to high humidity or extreme temperatures to maintain chemical stability. Storage conditions should comply with pharmaceutical guidelines to preserve potency and safety.